Prognostic Analysis of Liver Cirrhosis Patients with Cerebral Infarction And/or Gastrointestinal Hemorrhage: A Retrospective Cohort Study

Overview

Journal Comput Math Methods Med

Publisher Hindawi

Specialty Medical Informatics

Date 2022 Aug 15

PMID 35966248

Authors

Dianqiang Lu

Zhengyan Jiang

Xuezhen Zhai

Zhiguang Sun

Affiliations

Soon will be listed here.

Abstract

Background: To explore the risk factors of gastrointestinal hemorrhage and/or cerebral infarction complications in liver cirrhosis and provide evidence for early prevention, clinical diagnosis, and treatment of liver cirrhosis.

Methods: 200 liver cirrhosis patients were analyzed: liver cirrhosis ( = 78), liver cirrhosis complicated with cerebral infarction ( = 43), liver cirrhosis complicated with gastrointestinal hemorrhage ( = 57), and liver cirrhosis complicated with gastrointestinal hemorrhage and cerebral infarction ( = 22). The incidence of disease in each group of patients at different times was calculated. Multivariate logistic regression was used to analyze the risk factors of liver cirrhosis patients with gastrointestinal hemorrhage and cerebral infarction. After 12 months of follow-up, the mortality rate of each group was calculated.

Results: The incidences of gastrointestinal hemorrhage, cerebral infarction, and gastrointestinal hemorrhage combined with cerebral infarction in patients with liver cirrhosis were 21.5%, 28.5%, and 11%, respectively. The width of the portal vein, D-2 polymer, albumin (ALB), and hemoglobin (Hb) were predictors of gastrointestinal hemorrhage and cerebral infarction in patients with liver cirrhosis. Age, hypertension, bleeding history, infection, portal vein width, and D-2 polymer were confirmed as risk factors for gastrointestinal hemorrhage and cerebral infarction in patients with liver cirrhosis. ALB and Hb were independent protective factors. Patients with liver cirrhosis and gastrointestinal hemorrhage with cerebral infarction had the worst survival.

Conclusion: Age, hypertension, bleeding history, infection, portal vein width, and D-2 polymer are all independent risk factors for gastrointestinal bleeding and cerebral infarction, while ALB and Hb are independent protective factors.

Citing Articles

Retracted: Prognostic Analysis of Liver Cirrhosis Patients with Cerebral Infarction and/or Gastrointestinal Hemorrhage: A Retrospective Cohort Study.

Methods In Medicine C Comput Math Methods Med. 2023; 2023:9805415.

PMID: 37475909 PMC: 10356273. DOI: 10.1155/2023/9805415.

References

Zhang X, Qi X, Yoshida E, Mendez-Sanchez N, Hou F, Deng H . Ischemic stroke in liver cirrhosis: epidemiology, risk factors, and in-hospital outcomes. Eur J Gastroenterol Hepatol. 2017; 30(2):233-240. DOI: 10.1097/MEG.0000000000001011. View

Cook D, Guyatt G . Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients. N Engl J Med. 2018; 378(26):2506-2516. DOI: 10.1056/NEJMra1605507. View

Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I . Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol. 2016; 51(7):629-50. DOI: 10.1007/s00535-016-1216-y. View

Yousufuddin M, Young N . Aging and ischemic stroke. Aging (Albany NY). 2019; 11(9):2542-2544. PMC: 6535078. DOI: 10.18632/aging.101931. View

Zhang M, Huang S, Ye N, Wang X . Clinical characteristics and risk factors of patients with flupirtine-induced liver cirrhosis complicated with upper gastrointestinal bleeding. Am J Transl Res. 2021; 13(5):5582-5588. PMC: 8205751. View

Barnett R . Liver cirrhosis. Lancet. 2018; 392(10144):275. DOI: 10.1016/S0140-6736(18)31659-3. View

Kim J, Kim B, Kim D, Park C, Lee H, Joo M . Guidelines for Nonvariceal Upper Gastrointestinal Bleeding. Gut Liver. 2020; 14(5):560-570. PMC: 7492499. DOI: 10.5009/gnl20154. View

Xu X, Ding H, Li W, Xu J, Han Y, Jia J . Chinese guidelines on the management of liver cirrhosis (abbreviated version). World J Gastroenterol. 2020; 26(45):7088-7103. PMC: 7723671. DOI: 10.3748/wjg.v26.i45.7088. View

Cave D, Hakimian S, Patel K . Current Controversies Concerning Capsule Endoscopy. Dig Dis Sci. 2019; 64(11):3040-3047. DOI: 10.1007/s10620-019-05791-4. View

10.

Tripodi A, Primignani M, Mannucci P . Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged. Intern Emerg Med. 2009; 5(1):7-12. DOI: 10.1007/s11739-009-0302-z. View

11.

Kobayashi Y, Yahikozawa H, Takamatsu R, Watanabe R, Hoshi K, Ishii W . Left Upper Lung Lobectomy Is an Embolic Risk Factor for Cerebral Infarction. J Stroke Cerebrovasc Dis. 2017; 26(9):e177-e179. DOI: 10.1016/j.jstrokecerebrovasdis.2017.06.034. View

12.

Moller S, Sibbesen E, Madsen J, Bendtsen F . Indocyanine green retention test in cirrhosis and portal hypertension: Accuracy and relation to severity of disease. J Gastroenterol Hepatol. 2018; 34(6):1093-1099. DOI: 10.1111/jgh.14470. View

13.

Khoury T, Ayman A, Cohen J, Daher S, Shmuel C, Mizrahi M . The Complex Role of Anticoagulation in Cirrhosis: An Updated Review of Where We Are and Where We Are Going. Digestion. 2016; 93(2):149-59. DOI: 10.1159/000442877. View

14.

Chen S, Wan Q, Wang T, Zhang K . Fluid Biomarkers for Predicting the Prognosis of Liver Cirrhosis. Biomed Res Int. 2020; 2020:7170457. PMC: 7114768. DOI: 10.1155/2020/7170457. View

15.

Lenti M, Pasina L, Cococcia S, Cortesi L, Miceli E, Dominioni C . Mortality rate and risk factors for gastrointestinal bleeding in elderly patients. Eur J Intern Med. 2018; 61:54-61. DOI: 10.1016/j.ejim.2018.11.003. View

16.

Pinter M, Trauner M, Peck-Radosavljevic M, Sieghart W . Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open. 2016; 1(2):e000042. PMC: 5070280. DOI: 10.1136/esmoopen-2016-000042. View

17.

Parikh N, Navi B, Schneider Y, Jesudian A, Kamel H . Association Between Cirrhosis and Stroke in a Nationally Representative Cohort. JAMA Neurol. 2017; 74(8):927-932. PMC: 5710331. DOI: 10.1001/jamaneurol.2017.0923. View

18.

Butterworth R . Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology. Drugs. 2019; 79(Suppl 1):17-21. PMC: 6416236. DOI: 10.1007/s40265-018-1017-0. View

19.

Intagliata N, Caldwell S, Tripodi A . Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology. 2019; 156(6):1582-1599.e1. DOI: 10.1053/j.gastro.2019.01.265. View

20.

Bryant R, Kuo P, Williamson K, Yam C, Schoeman M, Holloway R . Performance of the Glasgow-Blatchford score in predicting clinical outcomes and intervention in hospitalized patients with upper GI bleeding. Gastrointest Endosc. 2013; 78(4):576-83. DOI: 10.1016/j.gie.2013.05.003. View